A single inhaled dose treated or even prevented infection by COVID-19 and its variants — ScienceDaily
A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human clinical trials…
